Review article: Epidemiology and management of gastro-oesophageal reflux in children

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 19, Issue 1, 2004, Pages 22-27

  Gold, B D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ADULT; AGE DISTRIBUTION; BODY POSITION; CAPSULE FILLING; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ENTERIC COATED TABLET; FEEDING; FOOD; GASTROESOPHAGEAL REFLUX; HEALTH CARE; HUMAN; INFANCY; INFANT; LIFESTYLE; LIQUID; LONG TERM CARE; PATHOPHYSIOLOGY; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STOMACH ACID; STRAWBERRY; SURGICAL TECHNIQUE; SUSPENSION; TREATMENT OUTCOME;

CHILD; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; MIDWESTERN UNITED STATES; PREVALENCE; PROTON PUMPS;

EID: 1342267813     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Barak N, Ehrenpreis ED, Harrison JR, Sitrin MD. Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations. Obesity Rev 2002; 3: 9-15.
2. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-98. J Am Med Assoc 2001; 286: 2845-8.
3. Wright CM, Parker L, Lamont D, Craft AW. Implications of childhood obesity for adult health: findings from thousand families' cohort study. Br Med J 2001; 323: 1280-4.
4. Romero Y, Cameron AJ, Schaid DJ, et al. Barrett's esophagus: prevalence in symptomatic relatives. Am J Gastroenterol 2002; 97: 1127-32.
5. Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 1997; 92: 1293-7.
6. Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N. Screening and surveillance for Barrett's esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 2003; 138: 176-86.
7. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
8. Rudolph CD, Mazur LJ, Liptak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001; 32: S1-31.
9. Vandenplas Y. Reflux esophagitis in infants and children: a report from the Working Group on Gastro-Oesophageal Reflux Disease of the European Society of Paediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1994; 18: 413-22.
10. Vandenplas Y. Physiopathological mechanisms of gastro-oesophageal reflux: is motility the clue? Rev Med Brux 1994; 15: 7-9.
11. Vandenplas Y, Belli D. Esophageal pH monitoring. J Pediatr Gastroenterol Nutr 1996; 23: 337-8(letter; comment).
12. Sondheimer JM. Continuous monitoring of distal esophageal pH: a diagnostic test for gastroesophageal reflux in infants. J Pediatr 1980; 96: 804-7.
13. Euler AR. Use of bethanechol for the treatment of gastroesophageal reflux. J Pediatr 1980; 96: 321-4.
14. Vandenplas Y, Bury F, Cadranel S, et al. Draft protocol for oesophageal pH monitoring. pH Monitoring Working-group of the Belgian Group of Paediatric Gastroenterology and Nutrition. Acta Gastroenterol Belg 1991; 54: 195-200.
15. Vandenplas Y. Esophageal pH monitoring: methodology, indication and interpretation. Eur J Pediatr Surg 1991; 1: 67-72.
16. Quigley EM. Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003; 98: S24-30.
17. Quigley EM. 24-h pH monitoring for gastroesophageal reflux disease, already standard but not yet gold? Am J Gastroenterol 1992; 87: 1071-5.
18. Kawahara H, Dent J, Davidson G. Mechanisms responsible for gastroesophageal reflux in children. Gastroenterology 1997; 113: 399-408.
19. Trudgill N. Familial factors in the etiology of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma. Chest Surg Clin N Am 2002; 12: 15-24.
20. Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR 3rd, Pedersen NL. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2002; 122: 55-9.
21. Hu FZ, Preston RA, Post JC, et al. Mapping of a gene for severe pediatric gastroesophageal reflux to chromosome 13q14. J Am Med Assoc 2000; 284: 325-34.
22. Orenstein SR, Shalaby TM, Finch R, et al. Autosomal dominant infantile gastroesophageal reflux disease: exclusion of a 13q14 locus in five well characterized families. Am J Gastroenterol 2002; 97: 2725-32.
23. Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Prac Res Group Arch Pediatr Adolesc Med 2000; 154: 150-4.
24. Dahl M, Thommessen M, Rasmussen M, et al. Feeding and nutritional characteristics in children with moderate or severe cerebral palsy. Acta Paediatr 1996; 6: 697-701.
25. Reilly S, Skuse D, Poblete X. Prevalence of feeding problems and oral motor dysfunction in children with cerebral palsy: a community survey. J Pediatr 1996; 6: 877-82.
26. Gisel EG, Birnbaum R, Schwartz S. Feeding impairments in children: diagnosis and effective intervention. Int J Orofacial Myol 1998; 24: 27-33.
27. Schwarz SM, Corredor J, Fisher-Medina J, et al. Diagnosis and treatment of feeding disorders in children with developmental disabilities. Pediatrics 2001; 108: 671-6.
28. Andze G, Brandt M, St-Vil D, et al. Diagnosis and treatment of gastroesophageal reflux in 500 children with respiratory symptoms: value of pH monitoring. J Pediatr Surg 1991; 26: 295-9.
29. Tucci F, Resti M, Fontana R, et al. Gastroesophageal reflux and bronchial asthma: prevalence and effect of cisapride therapy. J Pediatr Gastroenterol Nutr 1993; 17: 265-70.
30. Martin ME, Grunstein MM, Larsen GL. The relationship of gastroesophageal reflux to nocturnal wheezing in children with asthma. Ann Allergy 1982; 49: 318-22.
31. Gustafsson PM, Kjellman NI, Tibbing L. A trial of ranitidine in asthmatic children and adolescents with or without pathological gastro-oesophageal reflux. Eur Resp J 1992; 5: 201-6.
32. Balson BM, Kravitz EKS, McGeady SJ. Diagnosis and treatment of gastroesophageal reflux in children and adolescents with severe asthma. Ann Allergy Asthma Immunol 1998; 81: 159-64.
33. El-Serag HB, Bailey NR, Gilger M, Rabeneck L. Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Am J Gastroenterol 2002; 97: 1635-9.
34. Gibbons TE, Stockwell JA, Kreh RP, McRae SW, Gold BD. The status of gastroesophageal reflux disease in hospitalized U.S. children; 1995-2000. J Pediatric Gastroenterol Nutr 2001; 33: 197.
35. Beddow EC, Wilcox DT, Drake DP, Pierro A, Kiely EM, Spitz L. Surveillance of Barrett's esophagus in children. J Pediatr Surg 1999; 34: 88-90; discussion 91.
36. Waring JP, Feiler MJ, Hunter JG, Smith CD, Gold BD. Childhood gastroesophageal reflux symptoms in adult patients. J Pediatr Gastroenterol Nutr 2002; 35: 334-8.
37. Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric Prac Res Group Arch Pediatr Adolesc Med 1997; 151: 569-72.
38. Ofman JJ, Gralnek IM, Udani J, Fennerty MB, Fass R. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med 1999; 107: 219-27.
39. Chadwick LM, Kurinczuk JJ, Hallam LA, Brennan BA, Forbes D. Clinical and endoscopic predictors of histological oesophagitis in infants. J Paediatr Child Health 1997; 33: 388-93.
40. Hassall E. Macroscopic versus microscopic diagnosis of reflux esophagitis: erosions or eosinophils? J Pediatr Gastroenterol Nutr 1996; 22: 321-5.
41. Liacouras CA, Wenner WJ, Brown K, Ruchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998; 26: 380-5.
42. Ruchelli E, Wenner W, Voytek T, Brown K, Liacouras C. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol 1999; 2: 15-8.
43. Vandenplas Y, Goyvaerts H, Helven R, Sacre L. Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome. Pediatrics 1991; 88: 834-40.
44. Fackler WK, Vaezi MF, Richter JE. Ambulatory gastric pH monitoring: proper probe placement and normal values. Aliment Pharmacol Ther 2001; 15: 1155-62.
45. Tolia V, Ferry G, Gunasekaran T, Huang B, Keith R, Book L. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr 2002; 35: S308-S318.
46. Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group. J Pediatr 2000; 137: 800-7.
47. Fonkalsrud EW, Ashcraft KW, Coran AG, et al. Surgical treatment of gastroesophageal reflux in children: a combined hospital study of 7467 patients. Pediatrics 1998; 101: 419-22.
48. Fonkalsrud EW. Nissen fundoplication for gastroesophageal reflux disease in infants and children. Semin Pediatr Surg 1998; 7: 110-4.